Symbols / ETON Stock $23.61 +0.30% Eton Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
ETON (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Fundamentals
Scroll to Statements
Market Cap 644.19M Enterprise Value 649.33M Income -4.60M Sales 79.95M Book/sh 0.97 Cash/sh 0.95
Dividend Yield — Payout 0.00% Employees 44 IPO — P/E — Forward P/E 15.13
PEG — P/S 8.06 P/B 24.42 P/C — EV/EBITDA 73.16 EV/Sales 8.12
Quick Ratio 0.98 Current Ratio 1.57 Debt/Eq 118.85 LT Debt/Eq — EPS (ttm) -0.17 EPS next Y 1.56
EPS Growth — Revenue Growth 82.70% Earnings 2026-05-12 ROA 3.59% ROE -18.19% ROIC —
Gross Margin 59.83% Oper. Margin 20.99% Profit Margin -5.76% Shs Outstand 27.28M Shs Float 18.29M Short Float 7.29%
Short Ratio 4.56 Short Interest — 52W High 27.29 52W Low 13.09 Beta 0.97 Avg Volume 365.95K
Volume 209.56K Target Price $39.33 Recom Strong_buy Prev Close $23.54 Price $23.61 Change 0.30%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$39.33
Mean price target
2. Current target
$23.61
Latest analyst target
3. DCF / Fair value
$7.36
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$23.61
Low
$31.00
High
$52.00
Mean
$39.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-20 main B. Riley Securities Buy → Buy $31
2026-03-20 main HC Wainwright & Co. Buy → Buy $52
2026-03-20 main Craig-Hallum Buy → Buy $35
2026-03-03 main Craig-Hallum Buy → Buy $30
2026-03-02 main HC Wainwright & Co. Buy → Buy $37
2025-05-29 main HC Wainwright & Co. Buy → Buy $35
2025-05-16 reit B. Riley Securities Buy → Buy $26
2025-05-14 main Craig-Hallum Buy → Buy $28
2025-03-19 main Craig-Hallum Buy → Buy $26
2025-03-19 reit B. Riley Securities Buy → Buy $24
2025-03-19 reit HC Wainwright & Co. Buy → Buy $33
2025-01-23 main HC Wainwright & Co. Buy → Buy $33
2025-01-10 init B. Riley Securities — → Buy $21
2025-01-08 main Craig-Hallum Buy → Buy $18
2025-01-06 main HC Wainwright & Co. Buy → Buy $17
2024-11-26 reit HC Wainwright & Co. Buy → Buy $15
2024-11-13 reit HC Wainwright & Co. Buy → Buy $11
2024-10-28 main Craig-Hallum Buy → Buy $15
2024-10-04 main Craig-Hallum Buy → Buy $10
2024-10-04 main HC Wainwright & Co. Buy → Buy $11
News
RSS: Latest ETON news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-03 RIEDEL NORBERT G Director — 30,000 $4.42 $132,600
2025-08-20 GRUBER JAMES R Chief Financial Officer — 41,713 $16.02 $673,714
2025-06-16 KREMPA DAVID Officer — 34,000 $14.73 $504,318
2025-06-10 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 7,930 $15.82 $125,484
2025-06-05 BRYNJELSEN SEAN E Chief Executive Officer — 210,000 $16.81 $3,592,611
2025-01-03 RIEDEL NORBERT G Director — 102,400 $3.47 $373,842
2024-10-23 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 10,000 $7.98 $79,814
2024-10-08 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 62,070 $6.77 $434,137
2024-09-11 OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security — 107,500 $4.65 $504,875
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
79.95
+104.94%
39.01
+23.29%
31.64
+48.90%
21.25
Operating Revenue
79.95
+104.94%
39.01
+23.29%
31.64
+48.90%
21.25
Cost Of Revenue
37.21
+138.53%
15.60
+47.43%
10.58
+52.62%
6.93
Reconciled Cost Of Revenue
37.21
+138.53%
15.60
+47.43%
10.58
+52.62%
6.93
Gross Profit
42.74
+82.56%
23.41
+11.16%
21.06
+47.09%
14.32
Operating Expense
43.58
+67.58%
26.01
+16.87%
22.25
-1.44%
22.58
Research And Development
7.76
+138.56%
3.25
-2.02%
3.32
-16.87%
4.00
Selling General And Administration
35.82
+57.43%
22.75
+20.19%
18.93
+1.88%
18.58
General And Administrative Expense
35.82
+57.43%
22.75
+20.19%
18.93
+1.88%
18.58
Other Gand A
35.82
+57.43%
22.75
+20.19%
18.93
+1.88%
18.58
Total Expenses
80.79
+94.18%
41.61
+26.72%
32.83
+11.26%
29.51
Operating Income
-0.84
+67.50%
-2.60
-117.87%
-1.19
+85.57%
-8.26
Total Operating Income As Reported
-0.84
+67.50%
-2.60
-117.87%
-1.19
+85.57%
-8.26
EBITDA
3.20
+320.54%
-1.45
-398.63%
-0.29
+95.51%
-6.49
Normalized EBITDA
3.20
+320.54%
-1.45
-398.63%
-0.29
+95.51%
-6.49
Reconciled Depreciation
4.04
+252.88%
1.15
+27.19%
0.90
-49.21%
1.77
EBIT
-0.84
+67.50%
-2.60
-117.87%
-1.19
+85.57%
-8.26
Total Unusual Items
—
—
0.00
0.00
Total Unusual Items Excluding Goodwill
—
—
0.00
0.00
Special Income Charges
—
—
0.00
0.00
Other Special Charges
—
—
—
—
Net Income
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Pretax Income
-4.56
-19.70%
-3.81
-452.69%
-0.69
+92.36%
-9.02
Net Non Operating Interest Income Expense
-3.71
-206.69%
-1.21
-340.76%
0.50
+166.10%
-0.76
Net Interest Income
-3.71
-206.69%
-1.21
-340.76%
0.50
+166.10%
-0.76
Other Income Expense
—
—
—
—
Tax Provision
0.04
+186.67%
0.01
-93.93%
0.25
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Net Income From Continuing Operation Net Minority Interest
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Net Income From Continuing And Discontinued Operation
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Net Income Continuous Operations
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Normalized Income
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Net Income Common Stockholders
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Diluted EPS
—
-0.15
-275.00%
-0.04
+88.89%
-0.36
Basic EPS
—
-0.15
-275.00%
-0.04
+88.89%
-0.36
Basic Average Shares
—
25.89
+0.97%
25.64
+1.98%
25.15
Diluted Average Shares
—
25.89
+0.97%
25.64
+1.98%
25.15
Diluted NI Availto Com Stockholders
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Gain On Sale Of PPE
—
—
0.00
0.00
Total Other Finance Cost
3.71
+206.69%
1.21
+340.76%
-0.50
-166.10%
0.76
Line Item Trend 2023-12-31
Total Assets
31.74
Current Assets
26.84
Cash Cash Equivalents And Short Term Investments
21.39
Cash And Cash Equivalents
21.39
Receivables
3.41
Accounts Receivable
3.41
Gross Accounts Receivable
3.54
Allowance For Doubtful Accounts Receivable
-0.13
Inventory
0.91
Raw Materials
—
Work In Process
—
Finished Goods
—
Prepaid Assets
—
Other Current Assets
1.13
Total Non Current Assets
4.90
Net PPE
0.15
Gross PPE
0.55
Accumulated Depreciation
-0.40
Properties
0.00
Buildings And Improvements
0.09
Machinery Furniture Equipment
0.30
Construction In Progress
0.00
Other Properties
0.05
Leases
0.10
Goodwill And Other Intangible Assets
4.74
Other Intangible Assets
—
Other Non Current Assets
0.01
Total Liabilities Net Minority Interest
16.26
Current Liabilities
16.24
Payables And Accrued Expenses
10.86
Payables
1.85
Accounts Payable
1.85
Current Accrued Expenses
9.01
Current Debt And Capital Lease Obligation
5.38
Current Debt
5.38
Other Current Borrowings
5.38
Total Non Current Liabilities Net Minority Interest
0.02
Long Term Debt And Capital Lease Obligation
0.02
Long Term Debt
—
Long Term Capital Lease Obligation
0.02
Other Non Current Liabilities
—
Stockholders Equity
15.48
Common Stock Equity
15.48
Capital Stock
0.03
Common Stock
0.03
Share Issued
25.69
Ordinary Shares Number
25.69
Treasury Shares Number
0.00
Additional Paid In Capital
119.52
Retained Earnings
-104.07
Total Equity Gross Minority Interest
15.48
Total Capitalization
15.48
Working Capital
10.60
Invested Capital
20.86
Total Debt
5.40
Net Debt
—
Capital Lease Obligations
0.02
Net Tangible Assets
10.74
Tangible Book Value
10.74
Inventories Adjustments Allowances
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
10.52
+986.07%
0.97
-85.78%
6.82
+41.36%
4.82
Cash Flow From Continuing Operating Activities
10.52
+986.07%
0.97
-85.78%
6.82
+41.36%
4.82
Net Income From Continuing Operations
-4.60
-20.35%
-3.82
-308.44%
-0.94
+89.62%
-9.02
Depreciation Amortization Depletion
4.04
+252.88%
1.15
+27.19%
0.90
-49.21%
1.77
Depreciation And Amortization
4.04
+252.88%
1.15
+27.19%
0.90
-49.21%
1.77
Other Non Cash Items
5.83
+394.83%
1.18
+540.76%
0.18
-2.65%
0.19
Stock Based Compensation
5.51
+74.15%
3.17
+0.89%
3.14
-25.63%
4.22
Provisionand Write Offof Assets
0.59
+12.29%
0.53
+3426.67%
0.01
—
Operating Gains Losses
—
—
—
—
Gain Loss On Sale Of PPE
—
—
0.00
0.00
Change In Working Capital
-0.86
+29.99%
-1.23
-134.92%
3.51
-54.13%
7.66
Change In Receivables
-6.40
-105.13%
-3.12
-100.00%
-1.56
-143.08%
3.62
Changes In Account Receivables
-6.40
-105.13%
-3.12
-100.00%
-1.56
-143.08%
3.62
Change In Inventory
-5.88
-219.52%
-1.84
-398.37%
-0.37
-5171.43%
-0.01
Change In Prepaid Assets
-1.97
+41.15%
-3.35
-3662.77%
0.09
-94.89%
1.84
Change In Payables And Accrued Expense
10.27
+45.86%
7.04
+31.66%
5.35
+142.10%
2.21
Change In Accrued Expense
3.46
-26.70%
4.72
-10.80%
5.29
+138.84%
2.22
Change In Payable
6.81
+193.70%
2.32
+4273.58%
0.05
+762.50%
-0.01
Change In Account Payable
6.81
+193.70%
2.32
+4273.58%
0.05
+762.50%
-0.01
Change In Other Working Capital
3.11
+8094.74%
0.04
—
—
Investing Cash Flow
-0.33
+99.17%
-40.01
-5063.10%
-0.78
+72.20%
-2.79
Cash Flow From Continuing Investing Activities
-0.33
+99.17%
-40.01
-5063.10%
-0.78
+72.20%
-2.79
Net PPE Purchase And Sale
-0.33
-1180.77%
-0.03
0.00
+100.00%
-0.04
Purchase Of PPE
-0.33
-1180.77%
-0.03
0.00
+100.00%
-0.04
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-0.33
+96.67%
-10.01
-1192.13%
-0.78
+72.20%
-2.79
Net Business Purchase And Sale
0.00
+100.00%
-30.00
0.00
0.00
Purchase Of Business
0.00
+100.00%
-30.00
0.00
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-9.99
-1188.77%
-0.78
+71.82%
-2.75
Purchase Of Intangibles
0.00
+100.00%
-9.99
-1188.77%
-0.78
+71.82%
-2.75
Financing Cash Flow
0.81
-97.50%
32.59
+3505.75%
-0.96
-614.18%
-0.13
Cash Flow From Continuing Financing Activities
0.81
-97.50%
32.59
+3505.75%
-0.96
-614.18%
-0.13
Net Issuance Payments Of Debt
0.00
-100.00%
24.15
+2191.26%
-1.16
-200.00%
-0.39
Issuance Of Debt
0.00
-100.00%
25.31
0.00
0.00
Repayment Of Debt
0.00
+100.00%
-1.16
+0.00%
-1.16
-200.00%
-0.39
Long Term Debt Issuance
0.00
-100.00%
25.31
0.00
0.00
Long Term Debt Payments
0.00
+100.00%
-1.16
+0.00%
-1.16
-200.00%
-0.39
Net Long Term Debt Issuance
0.00
-100.00%
24.15
+2191.26%
-1.16
-200.00%
-0.39
Net Common Stock Issuance
0.00
-100.00%
7.00
0.00
0.00
Proceeds From Stock Option Exercised
0.81
-43.36%
1.44
+280.69%
0.38
+50.60%
0.25
Net Other Financing Charges
—
—
-0.18
—
Changes In Cash
11.01
+270.58%
-6.45
-226.93%
5.08
+167.67%
1.90
Beginning Cash Position
14.94
-30.17%
21.39
+31.17%
16.30
+13.18%
14.41
End Cash Position
25.94
+73.69%
14.94
-30.17%
21.39
+31.17%
16.30
Free Cash Flow
10.19
+212.67%
-9.04
-249.75%
6.04
+197.10%
2.03
Interest Paid Supplemental Data
3.33
+400.00%
0.67
-21.02%
0.84
+15.34%
0.73
Income Tax Paid Supplemental Data
0.12
+43.90%
0.08
-66.80%
0.25
0.00
Common Stock Issuance
0.00
-100.00%
7.00
0.00
0.00
Issuance Of Capital Stock
0.00
-100.00%
7.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category